Legis Daily

United States Pharmaceutical Supply Chain Review Act

USA117th CongressS-1367| Senate 
| Updated: 4/26/2021
Elizabeth Warren

Elizabeth Warren

Democratic Senator

Massachusetts

Cosponsors (1)
Marco Rubio (Republican)

Banking, Housing, and Urban Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-4191
United States Pharmaceutical Supply Chain Review Act
Apr 26, 2021
Introduced in Senate
Apr 26, 2021
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  • Bill from Previous Congress

    S 116-4191
    United States Pharmaceutical Supply Chain Review Act


  • April 26, 2021
    Introduced in Senate


  • April 26, 2021
    Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

Health

Related Bills

  • S 117-1366: Pharmaceutical Supply Chain Defense and Enhancement Act
Congressional oversightGeneticsGovernment information and archivesGovernment studies and investigationsHealth technology, devices, suppliesIndustrial policy and productivityManufacturingPrescription drugsRetail and wholesale tradesU.S. and foreign investments

United States Pharmaceutical Supply Chain Review Act

USA117th CongressS-1367| Senate 
| Updated: 4/26/2021
United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-4191
United States Pharmaceutical Supply Chain Review Act
Apr 26, 2021
Introduced in Senate
Apr 26, 2021
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  • Bill from Previous Congress

    S 116-4191
    United States Pharmaceutical Supply Chain Review Act


  • April 26, 2021
    Introduced in Senate


  • April 26, 2021
    Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Elizabeth Warren

Elizabeth Warren

Democratic Senator

Massachusetts

Cosponsors (1)
Marco Rubio (Republican)

Banking, Housing, and Urban Affairs Committee

Health

Related Bills

  • S 117-1366: Pharmaceutical Supply Chain Defense and Enhancement Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightGeneticsGovernment information and archivesGovernment studies and investigationsHealth technology, devices, suppliesIndustrial policy and productivityManufacturingPrescription drugsRetail and wholesale tradesU.S. and foreign investments